Cardiologists were asked to develop a care strategy for CAD patients before and after using an FDA-approved AI tool to evaluate CT results. In two out of three cases, the AI influenced cardiologists to modify their original plan. 

The past four years have witnessed major advancements in medical science’s drive to unravel the complexities of the human immune system. We have the COVID-19 pandemic to thank for much of the progress. 

The Evolut FX+ TAVR system includes an updated diamond-shaped frame, which was made four times larger than previous models to offer improved coronary access. It was also designed to provide more space for operators to guide and maneuver the catheter during procedures.

Buzzworthy developments of the past few days.

AI adoption for real-world healthcare settings can’t happen in a vacuum. 

HeartFlow hopes to gather real-world data from up to 10,000 patients with suspected CAD.

Members of Congress are now asking the FDA to investigate a parent's claim that her 14-year-old son was treated with an experimental heart valve without proper consent. The valve eventually failed and had to be replaced. The hospital has said its heart team did nothing wrong. 

“Most health systems rely on a financial cost-containment model to inform staffing decisions. Clinicians understand the patient populations and needs over time, yet they are currently excluded from most staffing decisions,” the authors write.